Evidence map›Paper›PMID 38206986›Full record

ArticleJournal of magnetic resonance imaging : JMRI2024

Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI.

Jingwen Yao, Melanie A Morrison, Angela Jakary, Sivakami Avadiappan, Paul Rowley, Julia Glueck, Theresa Driscoll, Michael D Geschwind, Alexandra B Nelson, Kathrine L Possin and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Non-canonical cell death in neurodegeneration: emerging mechanisms and therapeutic Frontiers.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Preoperative Functional Connectivity Predicts Antiparkinson Drug Change after Deep Brain Stimulation.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Jingwen YaoDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.ORCID 0000-0002-8828-1841
Melanie A MorrisonDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.ORCID 0000-0002-5993-0515
Angela JakaryDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.
Sivakami AvadiappanDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.
Paul RowleyDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.
Julia GlueckDepartment of Neurology, UCSF, San Francisco, California, USA.
Theresa DriscollDepartment of Neurology, UCSF, San Francisco, California, USA.
Michael D GeschwindDepartment of Neurology, UCSF, San Francisco, California, USA.
Alexandra B NelsonDepartment of Neurology, UCSF, San Francisco, California, USA.
Kathrine L PossinDepartment of Neurology, UCSF, San Francisco, California, USA.
Duan XuDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.
Christopher P HessDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.
Janine M LupoDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.ORCID 0000-0002-0051-6387
University of California, San Francisco · USUniversity of California, Los Angeles · US

Funding

IMPROVED MONITORING OF PREMANIFEST AND EARLY HUNTINGTONS USING 7T MULTIMODAL MRIR01NS099564 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HESS, CHRISTOPHER PAUL, LUPO, JANINE MARIE · 2017 to 2021
$3.0M
NINDS NIH HHS R01 NS099564
6 · The paper itself

Abstract

backgroundPathophysiological changes of Huntington's disease (HD) can precede symptom onset by decades. Robust imaging biomarkers are needed to monitor HD progression, especially before the clinical onset. PURPOSE: To investigate iron dysregulation and microstructure alterations in subcortical regions as HD imaging biomarkers, and to associate such alterations with motor and cognitive impairments. STUDY TYPE: Prospective. POPULATION: Fourteen individuals with premanifest HD (38.0 ± 11.0 years, 9 females; far-from-onset N = 6, near-onset N = 8), 21 manifest HD patients (49.1 ± 12.1 years, 11 females), and 33 age-matched healthy controls (43.9 ± 12.2 years, 17 females). FIELD STRENGTH/SEQUENCE: 7 T, T ASSESSMENT: Volume, susceptibility, fractional anisotropy (FA), and mean diffusivity (MD) within subcortical brain structures were compared across groups, used to establish HD classification models, and correlated to clinical measures and cognitive assessments. STATISTICAL TESTS: Generalized linear model, multivariate logistic regression, receiver operating characteristics with the area under the curve (AUC), and likelihood ratio test comparing a volumetric model to one that also includes susceptibility and diffusion metrics, Wilcoxon paired signed-rank test, and Pearson's correlation. A P-value <0.05 after Benjamini-Hochberg correction was considered statistically significant.

resultsSignificantly higher striatal susceptibility and FA were found in premanifest and manifest HD preceding atrophy, even in far-from-onset premanifest HD compared to controls (putamen susceptibility: 0.027 ± 0.022 vs. 0.018 ± 0.013 ppm; FA: 0.358 ± 0.048 vs. 0.313 ± 0.039). The model with additional susceptibility, FA, and MD features showed higher AUC compared to volume features alone when differentiating premanifest HD from HC (0.83 vs. 0.66), and manifest from premanifest HD (0.94 vs. 0.83). Higher striatal susceptibility significantly correlated with cognitive deterioration in HD (executive function: r = -0.600; socioemotional function: r = -0.486). DATA

conclusion7 T MRI revealed iron dysregulation and microstructure alterations with HD progression, which could precede volume loss, provide added value to HD differentiation, and might be associated with cognitive changes. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY: Stage 2.

Indexed as

Diffusion Tensor ImagingHuntington DiseaseIronMagnetic Resonance ImagingAdultBiomarkersBrainCase-Control StudiesFemaleHumansMaleMiddle AgedProspective StudiesBiomarkersIrondiffusion tensor imagingHuntington's diseaseneuroimagingquantitative susceptibility mappingsubcortical nuclei

Identifiers

PMID38206986
PMCPMC11521114
OpenAlexW4390735635

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.